世界经济论坛-从政策到实践：商业生物经济的可行建议（英）

From Policy to Practice: Actionable Recommendations for a Commercial Bioeconomy W H I T E P A P E RJ U N E 2 0 2 5In collaboration with CapgeminiImages: Getty ImagesDisclaimer This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic Forum but whose results do not necessarily represent the views of the World Economic Forum, nor the entirety of its Members, Partners or other stakeholders.© 2025 World Economic Forum. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, including photocopying and recording, or by any information storage and retrieval system.ContentsForeword 3Executive summary 4Introduction 51 Regulation 92 Incentives 153 Financing 204 Access and education 26Concluding remarks 32Contributors 33Endnotes 36From Policy to Practice: Actionable Recommendations for a Commercial Bioeconomy2ForewordThe bioeconomy represents one of the most profound opportunities of our time – a bridge between innovation and impact, science and society, economic growth and environmental stewardship. Bio-innovation’s potential to reshape industries, strengthen domestic supply chains, and create new models of national competitiveness is no longer theoretical. It is real, it is rising and it is ready to be scaled.Yet the bioeconomy stands at a crossroads. While the pace of technological advancement has been extraordinary, mainstream adoption remains limited. Too often, stakeholders lead with a technology-push approach, driven by scientific possibilities rather than market readiness. To unlock the full potential of bio-innovation, a fundamental shift is needed – one that ensures innovation is not only possible, but also commercially viable, regionally relevant and socially impactful.Amid rising geopolitical uncertainty, climate instability and economic volatility, governments and industry are under pressure to do more with less – driving inclusive growth, promoting innovation and cultivating resilience despite limited resources. In this new normal, bio-innovation must not be perceived as “nice to have”, but as a strategic imperative. A well-developed bioeconomy can be a powerful catalyst for new economic models, future-ready supply chains and national competitiveness – while advancing global sustainability.Across the globe, over 50 national strategies are focused on accelerating the bioeconomy. But strategy alone is not enough. Coordinated, actionable frameworks that deliver clear outcomes and remove barriers are needed urgently. This means policy environments that favour a market-pull dynamic – supported by compelling fiscal incentives, trustworthy regulation and tailored financial support mechanisms that enable breakthroughs to scale with speed and responsibility.Together with our global partner